However, when analyzed by grade, IDH mutation does not result in survival differences across astrocytomas of either grade-2 or grade-3 variants (p = 0.085 and 0.300, respectively) (Figure 9). This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).